Alison Frances Lawton - Jun 8, 2021 Form 4 Insider Report for Aeglea BioTherapeutics, Inc. (AGLE)

Role
Director
Signature
/s/ Joey Perrone, by power of attorney
Stock symbol
AGLE
Transactions as of
Jun 8, 2021
Transactions value $
$0
Form type
4
Date filed
6/9/2021, 05:24 PM
Previous filing
Jun 2, 2021
Next filing
Jun 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGLE Director Stock Option (right to buy) Award $0 +40K $0.00 40K Jun 8, 2021 Common Stock 40K $6.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in 12 equal monthly installments beginning on July 8, 2021, or on the date of the next annual meeting of stockholders, if earlier, subject to the continuing service of the Reporting Person on each vesting date.